Kapruvia® approved in Switzerland with additional regulatory decisions expected in H2 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
Source: apnews.com
Page 3 - Registry Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Registry Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Registry Study Today - Breaking & Trending Today
Kapruvia® approved in Switzerland with additional
Kapruvia® (difelikefalin) is the first and only therapy approved through consortium filing for the treatment of chronic kidney disease (CKD)-associated...
Source: globenewswire.com
Vifor Pharma Group: Kapruvia approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients
AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR First approved therapy in Europe for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients First launches
Source: finanznachrichten.de
Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients
Latest updates on this topic from reliable sources.
Source: financialpost.com